The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
On Jan. 11, 2019, AstraZeneca announced it had closed plants in Colorado and layed off 210 workers AstraZeneca…
On Nov. 1, 2018, the Earth BioGenome Project (EBP) was launched, a global effort to sequence the genetic…
On Sept. 27, 2018, Researchers from Scripps Institution of Oceanography at UCSD and the J. Craig Venter Institute…
On Aug. 22, 2018, University of California, San Diego (UCSD) researchers with colleagues in Spain and Finland, described…
On May 21, 2018, the National Cancer Institute awarded Keck School of Medicine of USC and USC Norris…
On May 14, 2018, University of California, Los Angeles (UCLA) researchers characterized the mechanism of the mammalian EAK-7…
On May 9, 2018, a new center dedicated to research on longevity and healthy aging was established at…
On Apr. 10, 2018, Amgen announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its 75-acre…
On Mar. 23, 2018, University of Southern California (USC) researchers launched a massive scientific effort to construct a…
On Mar. 19, 2018, the Priestley Medal was awarded to Geraldine Richmond by the American Chemical Society “to…
On Mar. 9, 2018, the Keck Medicine of University of Southern California (USC) significantly expanded its patient care…
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
On Nov. 1, 2017, a study from the Earth Microbiome Project reported the most extensive snapshot ever of…
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
On Jan. 23, 2017, scientists at The Scripps Research Institute (TSRI) announced the development of the first stable…
On Dec. 23, 2016, researchers at University of California (UC) Davis and California Department of Public Health announced…
On Sept. 29, 2016, University of Southern California (USC) Trustee Marc Benioff ’86 and his wife, Lynne, gifted…
On Sept. 21, 2016, the University of California, Berkeley, UC San Francisco and Stanford University joined forces in…
On Aug. 29, 2016, Scripps Health and MD Anderson Cancer Center announced a partnership agreement to create Scripps…
On Aug. 8, 2016, the National Institute on Drug Abuse announced a five-year grant totaling $11,714,623 to The…
On Jul. 5, 2016, The Stanford Cancer Institute announced it had been designated a Comprehensive Cancer Center by…
On Jun. 22, 2016, the Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP) voted…
On May 13, 2016, the White House Office of Science and Technology Policy (OSTP) announced a new National…
On May 12, 2016, technology entrepreneur and founder of Oracle, Larry Ellison announced the donation $200 million to…
On Apr. 13, 2016, the Parker Institute for Cancer Immunotherapy was created with a $250 million grant from…
On Apr. 11, 2016, the U.S. Food and Drug Administration (FDA) announced that it had granted accelerated approval…